Advertisement
Advertisement

CLOV

CLOV logo

Clover Health Investments, Corp

4.32
USD
Sponsored
-0.23
-5.05%
Jul 24, 15:56 UTC -4
Closed
exchange

Pre-Market

4.33

+0.01
+0.14%

CLOV Earnings Reports

Positive Surprise Ratio

CLOV beat 16 of 21 last estimates.

76%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$742.83M
/
$0.03
Implied change from Q1 26 (Revenue/ EPS)
-0.85%
/
-57.14%
Implied change from Q2 25 (Revenue/ EPS)
+55.53%
/
-250.00%

Clover Health Investments, Corp earnings per share and revenue

On May 06, 2026, CLOV reported earnings of 0.07 USD per share (EPS) for Q1 26, beating the estimate of 0.03 USD, resulting in a 128.76% surprise. Revenue reached 749.19 million, compared to an expected 729.19 million, with a 2.74% difference. The market reacted with a +5.22% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of 0.03 USD, with revenue projected to reach 742.83 million USD, implying an decrease of -57.14% EPS, and decrease of -0.85% in Revenue from the last quarter.
FAQ
For Q1 2026, Clover Health Investments, Corp reported EPS of $0.07, beating estimates by 128.76%, and revenue of $749.19M, 2.74% above expectations.
The stock price moved up 5.22%, changed from $2.68 before the earnings release to $2.82 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 5 analysts, Clover Health Investments, Corp is expected to report EPS of $0.03 and revenue of $742.83M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement